Is dongyangguang pharmaceutical a state-owned enterprise?

Dongyangguang Pharmaceutical is not a state-owned enterprise, but a private enterprise. Dongyangguang Pharmaceutical Co., Ltd. refers to Guangdong Dongyangguang Pharmaceutical Co., Ltd., which was established on February 29, 2003 with its registered address atNo. 1 Yegongbei Road, Songshan Lake Park, Dongguan City, Guangdong Province. As an important enterprise under the Oriental Sunshine Group, it is a high-tech enterprise focusing on pharmaceutical R&D, production and sales. The legal representative of the company is Zhang Yingjun, with a registered capital of 4,639,438.8+500,000 yuan.

Scope of business and products

Guangdong Dongyangguang Pharmaceutical Co., Ltd. has a wide range of business, including the production and sales of new dosage forms and new products (such as small-volume injections, tablets, capsules and granules) by adopting new technologies such as sustained release, controlled release, targeting and transdermal absorption. At the same time, the company is also committed to the research and development, production and sales of drugs and primary agricultural products. In addition, the import and export of goods and technology is also one of its important businesses.

In terms of products, the company has strong R&D strength, focusing on many therapeutic fields, such as hepatitis B, hepatitis C, tumors (including esophageal cancer, non-small cell lung cancer, acute myeloid leukemia, etc. ), endocrine and metabolic diseases (such as diabetes), etc. At present, the company has 50 1 new drug projects (of which 17 has been approved for clinical use), as well as a number of generic drugs and innovative preparations.

Production bases and facilities

Guangdong dongyangguang pharmaceutical co., ltd has advanced production bases and facilities. The company has production bases in Dongguan, Shaoguan, Guangdong and Yidu, Hubei, and is building new production bases in Jiangjin, Chongqing and Zunyi, Guizhou. These bases are designed and built according to international high standards, equipped with advanced production equipment and testing instruments.

Enterprise honor

2065438+February 2008, Guangdong Dongyangguang Pharmaceutical Co., Ltd. won the first prize of Guangdong Science and Technology Progress (research on key technologies of Cordyceps sinensis breeding and its industrial application).

From June 5438 to February 2023, Guangdong Dongyangguang Pharmaceutical Co., Ltd. was awarded the national intellectual property demonstration enterprise.

From June 5438 to February 2023, Guangdong Dongyangguang Pharmaceutical Co., Ltd. won the title of "the most innovative enterprise with R&D strength of the year" in the 4th China Biomedical Industry Chain Innovation Billboard in 2023.

Social responsibility and sustainable development

Guangdong Dongyangguang Pharmaceutical Co., Ltd. pursues economic benefits, but also actively fulfills its social responsibilities and is committed to sustainable development. The company strictly abides by national laws and regulations and relevant industry standards to ensure the safety and effectiveness of products. At the same time, the company also actively participates in social welfare undertakings and charitable activities, and contributes to the harmonious development of society.

Future prospects

In the future, Guangdong Dongyangguang Pharmaceutical Co., Ltd. will continue to adhere to the concept of "innovation and internationalization", increase investment in scientific research and platform construction, introduce more high-quality talents, and promote greater breakthroughs in new drug research and development and innovation. At the same time, the company will further expand the domestic and international markets, enhance the brand influence, and provide more high-quality and efficient drugs and services for patients around the world.